Volatile organic compounds in patients with primary ciliary dyskinesia with or without prophylactic azithromycin - Amsterdam 2025

Bronchiectasis: patient-centred outcomes and therapy

Chair(s): Yeon Mok Oh, William Flowers

Session type: Poster session

Volatile organic compounds in patients with primary ciliary dyskinesia with or without prophylactic azithromycin

Akash Singh

EVENTS HOME

Poster
Abstract

Previous presentation

Next presentation

Session content

Linking daily symptoms to exacerbations in bronchiectasis: findings from the Bronchiectasis Health Questionnaire

Charlotte Schou

Poster

Abstract

Airway CD10/neprilysin is related to lung function and disease severity in patients with bronchiectasis: Preliminary data from the EMBARC BRIDGE study

Hannah Dickson

Poster

Abstract

Inhaled Antibiotic Therapy in Patients with COPD and Chronic Bronchial Infection (CBI) by P. aeruginosa: Mortality Analysis Based on Eradication vs. Persistence of CBI

Fredy Bustamante Villanueva

Abstract

Urinary and fecal dysfunction in bronchiectasis patients: a pilot study

Martina Santambrogio

Poster

Abstract

Sex and gender in bronchiectasis: an analysis of two Italian centres and a review of literature

Ilaria Giana

Poster

Abstract

A prospective UK study to evaluate the bronchiectasis impact measure in patients with bronchiectasis: data from the EMBARC-BRIDGE study

Holly Lind

Abstract

Pan-European validation of the Bronchiectasis Health Questionnaire: data from the EMBARC-BRIDGE study

Arietta Spinou

Poster

Abstract

Validation of bronchiectasis patient reported outcome measures in adults with primary ciliary dyskinesia: Data from the EMBARC-BRIDGE study and BEAT-PCD

Amelia Shoemark

Poster

Abstract

Characterising adult Primary ciliary dyskinesia (PCD) in the EMBARC-BRIDGE cohort

Amelia Shoemark

Poster

Abstract

Are postal sputum samples a valid tool for clinical and research applications in bronchiectasis?

Louise Jackson

Poster

Abstract

Evaluating the role of telerehabilitation in managing bronchiectasis: a randomized study

Büsra Öçal

Poster

Abstract

Performance of artificial intelligence answering questions on disease management from people with bronchiectasis: results from the AIR-BE study.

Mattia Nigro

Poster

Abstract

Association between participation in the German Bronchiectasis Registry (PROGNOSIS) and improvement in the course of disease

Pontus Mertsch

Poster

Abstract

Interleukin-17C governs interleukin-17A pathogenicity and orchestrates asthma endotype switching in bronchiectasis.

Yuwei Zhang

Poster

Abstract

Effectiveness of pulmonary rehabilitation in bronchiectasis patients: comparing airway clearance device and physical activity

Fabrizia La Torre

Poster

Abstract

Probabilistic modelling to mitigate AMR development in bronchiectasis an AMR-Lung study

Ollie Pitts

Poster

Abstract

Volatile organic compounds in patients with primary ciliary dyskinesia with or without prophylactic azithromycin

Akash Singh

Poster

Abstract

Bronchiectasis Patients' awareness on RSV-LRTI and attitude to vaccination.

Virginia Santello

Poster

Abstract

Ethnicity and socioeconomic status have no impact on longitudinal spirometry trend for children and young people (CYP) with non-cystic fibrosis bronchiectasis (NCFB)

Jui Prashant Andharia

Poster

Abstract

Steady state signs and symptoms of bronchiectasis in an international multicentre cohort: the 4S study

Mattia Nigro

Poster

Abstract

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}